Enpro Earnings Call Transcripts
Fiscal Year 2025
-
Sales grew 9% to $1.14B in 2025, driven by aerospace, biopharma, and semiconductor markets, with strong Q4 results and robust free cash flow. 2026 guidance calls for 8%-12% sales growth, margin expansion, and continued strategic M&A.
-
Q3 2025 saw nearly 10% organic sales growth, strong segment margins, and robust free cash flow. Updated 2025 guidance reflects higher revenue and EBITDA, with recent acquisitions set to drive further growth and margin expansion in 2026.
-
Q2 2025 saw 6% sales growth, led by AST and resilient sealing performance, despite FX headwinds. Full-year guidance was raised for sales, EBITDA, and EPS, with strong cash flow, expanded credit, and continued investment in growth and M&A opportunities.
-
Enpro is executing its Enpro 3.0 strategy, emphasizing accelerated growth, margin expansion, and portfolio optimization through targeted M&A and organic investments. The company is well positioned in sealing and semiconductor markets, with strong aftermarket resilience and a disciplined capital allocation approach.
-
Q1 2025 saw 6% organic sales growth and 16% higher adjusted EBITDA, with both Sealing Technologies and AST segments delivering strong margins and market share gains. Guidance for 2025 is unchanged, with minimal tariff exposure and robust demand across key markets.
-
Enpro detailed its transformation into a high-margin industrial technology leader, emphasizing its successful portfolio optimization, margin expansion, and strategic acquisitions. The company targets mid-single digit organic growth, high double-digit growth with M&A, and sustained 30%+ EBITDA margins in both segments, with continued investments in semiconductor and sensor technologies.
Fiscal Year 2024
-
Strong 2024 results were driven by Sealing Technologies, offsetting AST softness, with adjusted EBITDA up 7% year-over-year and robust free cash flow. 2025 guidance anticipates low to mid-single-digit sales growth, continued margin strength, and increased CapEx for growth initiatives.
-
A major portfolio transformation has led to higher margins and a focus on critical engineering solutions in sealing and semiconductor markets. Despite market softness, both segments deliver strong EBITDA margins, with growth driven by operational excellence, strategic pricing, and targeted M&A.
-
Q3 2024 saw 4% sales growth and strong margins, but persistent softness in semiconductor and commercial vehicle OEM markets led to a downward revision of full-year guidance. Sealing Technologies outperformed, while AST faced margin pressure from choppy demand and accelerated investments.
-
Q2 2024 saw record profitability with adjusted EBITDA margin above 27%, driven by strong Sealing Technologies performance and sequential improvement in AST. 2024 guidance was narrowed, with sales expected flat year-over-year and gradual recovery in semiconductor markets anticipated.